DeepMed Research

COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies

Not Applicable

Recruiting

Conditions: Pancreatic Cyst

Interventions: Procedure: 2). EUS-FNA Alone
Procedure: 1). EUS-FNA plus MFB

First Posted Date: 2020-05-27

Last Posted Date: 2024-05-21

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 300

Registration Number: NCT04404101

Locations: 🇺🇸
University of California Irvine, Irvine, California, United States
🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States

Pulmonary Health in Children With Down Syndrome

Recruiting

Conditions: Dysphagia, Oropharyngeal
Down Syndrome

First Posted Date: 2020-05-21

Last Posted Date: 2024-01-26

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 75

Registration Number: NCT04398862

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

The Early and Late Contribution of Fasting and Postprandial Triglycerides on Newborn Subcutaneous and Intrahepatic Fat in Pregnancy

Recruiting

Conditions: Pregnancy

First Posted Date: 2020-05-19

Last Posted Date: 2024-10-04

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 140

Registration Number: NCT04394806

Locations: 🇺🇸
University of Colorado/Anschutz Medical Campus, Aurora, Colorado, United States

Surgical Telemedicine in the COVID-19 Pandemic Era

Completed

Conditions: Surgery
COVID

Interventions: Other: Completion of pre-pandemic survey
Other: Completion of post telemedicine encounter survey
Other: Completion of survey after peak of pandemic

First Posted Date: 2020-05-06

Last Posted Date: 2020-10-28

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 180

Registration Number: NCT04376710

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Preventing Alcohol Exposed Pregnancy Among Urban Native Young Women: Mobile CHOICES

Not Applicable

Completed

Conditions: Alcohol Exposed Pregnancy

Interventions: Behavioral: Native WYSE CHOICES

First Posted Date: 2020-05-06

Last Posted Date: 2024-04-17

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 439

Registration Number: NCT04376346

Locations: 🇺🇸
University of Colorado- Anschutz Medical Campus, Aurora, Colorado, United States

FMT as a Treatment for Severe Motility Disorder

Phase 1

Withdrawn

Conditions: Severe Motility Disorder

Interventions: Biological: FMT Lower Delivery (FMP 30)

First Posted Date: 2020-05-04

Last Posted Date: 2022-05-06

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT04373252

Convalescent Plasma for the Treatment of Patients With COVID-19

Conditions: COVID-19
SARS-CoV 2

First Posted Date: 2020-05-04

Last Posted Date: 2020-08-28

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT04372368

Locations: 🇺🇸
UCHealth Memorial Hospital North, Colorado Springs, Colorado, United States
🇺🇸
UCHealth Highlands Ranch Hospital, Highlands Ranch, Colorado, United States
🇺🇸
UCHealth Poudre Valley Hospital, Fort Collins, Colorado, United States

and more 3 locations

Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial

Phase 2

Withdrawn

Conditions: COVID-19
ARDS

Interventions: Drug: Dexamethasone injection
Drug: Placebos

First Posted Date: 2020-04-24

Last Posted Date: 2020-10-28

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT04360876

Therapeutic Omegas for Triglyceride Suppression

Not Applicable

Recruiting

Conditions: Pregnancy

Interventions: Dietary Supplement: Intervention Omega 3 Supplementation
Dietary Supplement: Control Safflower Oil

First Posted Date: 2020-04-16

Last Posted Date: 2024-10-04

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 40

Registration Number: NCT04349475

Locations: 🇺🇸
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
🇺🇸
University of Colorado/Anschutz Medical Campus, Aurora, Colorado, United States

Safety and Efficacy of Ruxolitinib for COVID-19

Phase 2

Withdrawn

Conditions: COVID-19

Interventions: Drug: Ruxolitinib

First Posted Date: 2020-04-15

Last Posted Date: 2021-03-08

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT04348071

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy